Literature DB >> 12534811

Employment of broad-range 16S rRNA PCR to detect aetiological agents of infection from clinical specimens in patients with acute meningitis--rapid separation of 16S rRNA PCR amplicons without the need for cloning.

J Xu1, B C Millar, J E Moore, K Murphy, H Webb, A J Fox, M Cafferkey, M J Crowe.   

Abstract

AIMS: The aim of this study was to develop a polyacrylamide gel electrophoresis (PAGE) method for the rapid separation of 16S rRNA PCR amplicons from aetiological agents of acute meningitis. METHODS AND
RESULTS: Blood samples from 40 patients with suspected acute meningococcal meningitis were examined for the presence of causal agents, including Neisseria meningitidis employing two methods: (i) broad-range 16S rRNA PCR in conjunction with PAGE and automated sequencing and (ii) species-specific PCR employing ABI TaqMan technology for N. meningitidis. Analysis of clinical specimens employing 16S rRNA PCR yielded 33/40 (82.5%) positive for the presence of bacterial DNA. Species-specific PCR yielded 30/40 (75%) clinical specimens positive for N. meningitidis. Prior to separation by PAGE, only 6/33 (18.2%) amplicons were able to be identified by sequence analysis, the remaining amplicons (n=27) did not yield an identification due to the presence of mixed 16S rRNA PCR amplicons. Following separation, amplicons were re-amplified and sequenced, yielding 24/27 (88.9%) positive for N. meningitidis and three specimens positive for Acinetobacter sp., Staphylococcus aureus and Streptococcus pneumoniae. One specimen was positive for both N. meningitidis and Streptococcus spp. and another specimen was positive for N. meningitidis and Pseudomonas sp., by broad-range PCR. Seven clinical specimens were negative for N. meningitidis and other eubacteria using both detection techniques.
CONCLUSIONS: Clinical specimens including blood and cerebrospinal fluid from patients with suspected acute bacterial meningitis, may become contaminated with commensal skin flora, resulting in difficulties in downstream sequencing of pathogen plus contaminant DNA. This study allows for the rapid separation of amplified pathogen from contaminant DNA. SIGNIFICANCE AND IMPACT OF STUDY: This study demonstrated the usefulness of the rapid separation of multiple 16S rRNA PCR amplicons using a combination of PAGE and automated sequencing, without the need of cloning. Adoption of this technique is therefore proposed when trying to rapidly identify pathogens in clinical specimens employing broad-range 16S rRNA PCR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534811     DOI: 10.1046/j.1365-2672.2003.01839.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  19 in total

1.  Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting.

Authors:  Tim Schuurman; Richard F de Boer; Anna M D Kooistra-Smid; Anton A van Zwet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection.

Authors:  M Marín; J M Garcia-Lechuz; P Alonso; M Villanueva; L Alcalá; M Gimeno; E Cercenado; M Sánchez-Somolinos; C Radice; E Bouza
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  Use of quantitative broad-based polymerase chain reaction for detection and identification of common bacterial pathogens in cerebrospinal fluid.

Authors:  Richard Rothman; Padmini Ramachandran; Samuel Yang; Andrew Hardick; Helen Won; Aleksandar Kecojevic; Celeste Quianzon; Yu-Hsiang Hsieh; Charlotte Gaydos
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

4.  Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level.

Authors:  Abdessalam Cherkaoui; Jonathan Hibbs; Stéphane Emonet; Manuela Tangomo; Myriam Girard; Patrice Francois; Jacques Schrenzel
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

5.  Use of universal 16S rRNA gene PCR as a diagnostic tool for venous access port-related bloodstream infections.

Authors:  M Guembe; M Marín; P Martín-Rabadán; A Echenagusia; F Camúñez; G Rodríguez-Rosales; G Simó; M Echenagusia; E Bouza
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

6.  Detection of Bacterial Pathogens in Cerebrospinal Fluid using Restriction Fragment Length Polymorphism.

Authors:  A T Kalghatgi; A K Praharaj; A K Sahni; D Pradhan; S Kumaravelu; P L Prasad; A Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters.

Authors:  Andrew Birtles; Katie Hardy; Stephen J Gray; Suzanne Handford; Edward B Kaczmarski; Valerie Edwards-Jones; Andrew J Fox
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Rapid diagnosis of bacterial meningitis in children with fluorescence quantitative polymerase chain reaction amplification in the bacterial 16S rRNA gene.

Authors:  Qun-Jun Duan; Shi-Qiang Shang; Yi-Dong Wu
Journal:  Eur J Pediatr       Date:  2008-06-12       Impact factor: 3.183

9.  Evaluation of a broad range real-time polymerase chain reaction (RT-PCR) assay for the diagnosis of septic synovitis in horses.

Authors:  Colette R Elmas; Judith B Koenig; Dorothee Bienzle; Nicola C Cribb; Natalia Cernicchiaro; Nathalie M Coté; J Scott Weese
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

Review 10.  Tropheryma whipplei infective endocarditis as the only manifestation of Whipple's disease.

Authors:  Mercedes Marín; Patricia Muñoz; Mónica Sánchez; Marina del Rosal; Marta Rodríguez-Créixems; E Bouza
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.